NICE rejects second Alzheimer’s drug but opportunity remains for decision change: GlobalData
NICE's rejection of Kisunla raises cost-effectiveness concerns but future approval remains possible pending further evidence
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Alzheimers
Shares of Japan’s Eisai tumble after EU rejects Alzheimer’s drug
EU regulator cites brain swelling risks, impacting Eisai and Biogen, and sparking concerns over global sales and market perception…
PharmaKure’s novel blood test can identify biomarkers in patients with Alzheimer’s Disease:…
Study confirms ALZmetrix whole blood test can detect people at high risk of developing full Alzheimer’s Disease
Cipla Foundation, NIMHANS set up neuro-palliative care unit in Bengaluru
The unit will provide support to individuals with neurological conditions such as Alzheimer's, Dementia, and Parkinson's, through…
Otsuka Pharma gets USFDA approval for Brexpiprazole to treat Alzheimer’s agitation
Brexpiprazole was previously approved in the US to treat adults with major depressive disorder and schizophrenia
Researchers from Tel Aviv University develop process that could reverse early signs of…
The new non-drug method holds promise for preventative therapies
Biogen to buy early-stage potential Alzheimer’s, Parkinson’s treatment from Pfizer
Under the deal, Pfizer will get $75 million upfront and will be eligible for $635 million in potential milestone payments
Lupin receives approval for generic Aricept tablets
The drug is indicated for the treatment of dementia of the Alzheimer's type
Aurobindo Pharma receives US FDA Approval for Alzheimer’s drug
The approved product has an estimated market size of $1.23 billion according to IMS Aurobindo Pharma has received the final…
Unichem Labs receives US FDA approval for memantine hydrochloride tabs
Memantine hydrochloride is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type